Arvelle Therapeutics is a biopharmaceutical company focused on developing innovative solutions for patients suffering from CNS disorders
Arvelle Therapeutics is a biopharmaceutical company focused on developing innovative solutions for patients suffering from CNS disorders. They are responsible for the development and commercialization of cenobamate, an investigational antiepileptic drug, in the European market.